Evaluating clinical utility of comprehensive genomic profiling-challenges and opportunities
J Natl Cancer Inst
.
2025 Jan 1;117(1):6-8.
doi: 10.1093/jnci/djae237.
Authors
Lisa M McShane
1
,
Lyndsay N Harris
2
Affiliations
1
Biometric Research Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA.
2
Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA.
PMID:
39514678
PMCID:
PMC11717416
DOI:
10.1093/jnci/djae237
No abstract available
Publication types
Comment
Grants and funding
CA/NCI NIH HHS/United States
NH/NIH HHS/United States
HH/HHS/United States